EASL Digital #NAFLDSummit 2021: Resonance Health presents, HepaFat-AI results equivalent to a conventional MRS technique

Resonance Health attended the EASL Digital NAFLD Summit 2021 on 16 - 17 September and participated with insights into developments in artificial intelligence-based approaches to NAFLD management using HepaFat-AI.

We are delighted to present the abstract we shared titled "Diagnostic accuracy of liver steatosis using artificial intelligence".

To read it please click here.